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Acanthamoeba culbertsoni is an opportunistic free-living amoeba that is causative 
of granulomatous amoebic encephalitis (GAE), a chronic and often fatal central nervous 
system (CNS) disease that is most prevalent in immune compromised individuals. One 
hallmark of this disease is the formation of granulomas within the CNS, which are 
commonly absent in immune compromised individuals. Granulomas are usually 
composed of amoebae, microglia (CNS macrophages), macrophages, T cells, B cells, and 
neutrophils.  Previous studies have demonstrated that microglia respond to 
Acanthamoeba by producing pro-inflammatory cytokines such as tumor necrosis factor 
xi 
alpha (TNF)-α, interleukin (IL)-1α, and IL-1β.   In addition, activated microglia and 
macrophages have been demonstrated to be cytolytic (i.e., amoebicidal) to 
Acanthamoeba.  Furthermore, previous studies also indicated that Acanthamoeba secrete 
a myriad of factors including proteases.  The role of these proteases during GAE has not 
been fully elucidated; however, it is thought that these factors may aid in the chronic 
persistence of Acanthamoeba within the CNS by modulating the host immune response.  
Using two-dimensional (iso-dalt) gel electrophoresis, we demonstrated that A. 
culbertsoni secrete factors that degrade culture medium proteins.  Initial gelatin 
zymography studies demonstrated that propagation of A. culbertsoni in medium with high 
iron content leads to augmentation of protease activity. Gelatin zymography in concert 
with protease inhibitors demonstrated that A. culbertsoni secrete proteases predominantly 
of the serine protease class.   Using an in vitro co-culture model, we demonstrated that 
co-culture of A. culbertsoni with mouse microglial-like cells (BV-2 cells) results in the 
augmentation of A. culbertsoni serine protease activity and stimulation of pro-
inflammatory cytokine and chemokine protein expression by microglial-like cells.  
However, the A. culbertsoni-elicited proteases were shown to degrade microglial-like cell 
elicited cytokines and chemokines.  Collectively, our results suggest that A. culbertsoni- 
secreted serine proteases may play a role in A. culbertsoni CNS immune evasion by 
increasing A. culbertsoni CNS dissemination via the diminution of granuloma formation 
and by dampening microglial-dependent cytokine response.       
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Introduction 
 
Acanthamoeba belong to a group of opportunistic free-living amoebae, including 
Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea, which have the 
ability to cause disease in humans [Visvesvara et al. 2007].  Acanthamoeba are classified 
in the kingdom Protista, phylum Rhizopodia, class Lobosa, order Amoebida, family 
Acanthamoebidae, genus Acanthamoeba.  Acanthamoeba are found worldwide and have 
been isolated from a variety of environmental sources including air, soil, dust, tap water, 
freshwater, seawater, swimming pools, air conditioning units, and contaminated contact 
lens cases [Marciano-Cabral and Cabral 2003].  Acanthamoeba reproduce by binary 
fission and have two life cycle stages; the actively feeding trophozoite and the dormant 
cyst (Figure 1). The trophozoite stage represents the infective form of Acanthamoeba. 
Morphologically, trophozoites average 12-35 μm in size, have a nucleus with a large 
central nucleolus, and express spine-like projections called acanthapodia [Marciano-
Cabral and Cabral 2003; Khan 2006].  In the environment the trophozoite feeds on 
bacteria (with a preference for gram-negative bacteria), algae, and yeast [Rodriquez-
Zaragoza et al. 1994; Visvesvara et al. 2007].  A double-walled round cyst, which ranges 
in size from 5-20 μm, is formed during unfavorable environmental conditions such as 
extreme temperature or pH changes [Marciano-Cabral and Cabral 2003; Khan 2006].  
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Figure 1: Life Cycle Forms of Acanthamoeba.  Scanning electron micrographs of 
Acanthamoeba (A) trophozoites displaying characteristic acanthapodia (arrows) and (B) 
cyst. The scale bars designate 10 µm and 1 µm in A and B, respectively.  Courtesy of Dr. 
Francine Marciano-Cabral, Ph.D.  
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Grouping of Acanthamoeba species was originally established using cyst 
morphology [Page 1967; Pussard and Pons 1977].  Using this criterion, species of 
Acanthamoeba were divided into three groups based on having large cysts (Group I), 
wrinkled ectocyts and endocysts with a triangular, polygonal, or oval morphology (Group 
II), or smooth ectocytes and round endocyts (Group III).  This classification scheme 
proved to be challenging as cyst morphology may vary depending on conditions [Sawyer 
and Griffin 1975].   Today, Acanthamoeba are grouped based on nuclear 18S ribosomal 
rRNA sequence differences.  Using this classification scheme, 12 different genotypes 
(T1-T12) have been described [Stothard et al. 1998].  Most of the pathogenic 
Acanthamoeba species belong to the T4 genotype [Khan 2006]. Table 1 lists the 
classification of Acanthamoeba that have been linked to disease in humans.   
Of the approximately 20 species of Acanthamoeba that have been identified, only 
twelve (A. astronyxis, A. castellanii, A. culbertsoni, A. divionesis, A. griffini, A. hatchetti, 
A. healyi, A. lenticulata, A. lugdunensis, A. polyphaga, A. quina, and A. rhysodes) have 
been linked to human disease [Marciano-Cabral and Cabral 2003; Visvesvara et al. 2007; 
Centers for Disease Control].  Acanthamoeba are associated with an eye infection known 
as amoebic keratitis (AK), a chronic and slow progressing central nervous (CNS) system 
disease called granulomatous amoebic encephalitis (GAE), and a skin infection called 
cutaneous acanthamoebiasis [Marciano-Cabral and Cabral 2003; Khan 2006; Visvesvara 
et al. 2007].  It has been reported that approximately 80% of the normal human 
population has serum antibodies against Acanthamoeba; however, Acanthamoeba 
infections are generally rare and usually are found in individuals who have a  
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Table 1 – Genotypes of Acanthamoeba Associated with Disease 
in Humans 
 
 
Species                  Sequence Type                    Morphological  
Group                                                                              
A. astronyxis                                T7                                                                  I 
 
A. castellanii                                T4                                                                  II 
 
A. culbertsoni                               T10                                                               III 
 
A. divionensis                               T4                                                                  II                                                                    
 
A. griffini                                      T3                                                                  II 
 
A. hatchetti                                   T11                                                                II 
 
A. healyi                                       T12                                                                III 
 
A. lenticulata                                T5                                                                  III 
 
A. lugdunensis                              T4                                                                  II 
 
A. polyphaga                                T4                                                                   II 
 
A. quina                                        unknown                                                       II 
 
A. rhysodes                                   T4                                                                  II 
 
 
Adapted from Stothard et al. 1998; Marciano-Cabral and Cabral 2003; Kilic et al. 2004. 
 
5 
predisposition for Acanthamoeba infection (i.e., contact lens wearers and immune 
compromised individuals; discussed below) [Chappell et al. 2001].   
AK is potentially a blinding eye infection and represents the most common 
disease caused by Acanthamoeba in humans [Clarke and Niederkorn 2006a]. 
Acanthamoeba that have been linked to AK include A. castellanii, A. polyphaga, A. 
hatchetti, A. culbertsoni, A. rhysodes, A. griffini, A. quina, and A. lugdunensis [Marciano-
Cabral and Cabral 2003].  This disease is most commonly associated with contact lens 
wearers and those who have experienced corneal trauma [Niederkorn et al. 1999]. The 
prevalence of this disease in contact lens wearers is thought to be associated with 
exposure to contaminated water and/or contact lens solutions.  Additionally, used contact 
lenses are thought to provide unique environments that facilitate Acanthamoeba biofilm 
formation on their surface, thus increasing the likelihood of infection [Khan 2006].  
Adhesion of Acanthamoeba trophozoites to the corneal epithelium via a trophozoite 
expressed mannose binding protein (MBP) is the first step in AK infection [Clarke and 
Niederkorn 2006b].   Invasion of the cornea is facilitated by Acanthamoeba factors such 
as extracellular matrix specific binding proteins and proteases (discussed below). 
Symptoms of AK include photophobia, excessive tearing, and ocular pain [Marciano-
Cabral and Cabral 2003].  One hallmark of this disease is the development of an ocular 
ring which results from immune cell infiltration.  AK is diagnosed via corneal biopsy and 
confocal microscopy [Visvesvara et al. 2007]. This infection is most successfully treated 
when caught in its earliest stages.  Chemotherapeutics used to treat AK include 
6 
polyhexamethylene biguanide (PHMB) or chlorhexidine digluconate (CHX) in 
combination with propamidine isethionate (Brolene) [Khan 2006; Visvesvara et al. 2007]. 
The innate immune system is thought to be the primary host resistance element 
involved in AK immunity. Diminution of macrophage and neutrophil responses in in 
vitro and in vivo models of AK have been demonstrated to result in an increase in disease 
severity; thus, these immunocytes are thought to represent the primary cells that act 
against corneal invading Acanthamoeba [van Klink et al. 1996; Hurt et al. 2003c; Clarke 
and Niederkorn 2006a].  Although the innate immune system is primarily involved in 
controlling AK, secretory IgA (sIgA), a component of the adaptive immune system that is 
normally found in tears, also is thought to play a role in resistance to AK infection. 
Secretory IgA is thought to prevent the adhesion of trophozoites to corneal epithelium, to 
augment the action of neutrophils, and to inhibit the deleterious actions of Acanthamoeba 
secreted proteases [van Klink et al. 1997; Leher et al. 1998; Hurt et al. 2003b; Said et al. 
2004; Clarke and Niederkorn et al. 2006a]   
Acanthamoeba also can cause a cutaneous or disseminated infection known as 
cutaneous acanthamoebiasis. Cutaneous acanthamoebiasis can occur in immune 
competent individuals; however, it is associated more frequently with immune 
compromised individuals [Marciano-Cabral and Cabral 2003]. It is thought that 
cutaneous Acanthamoeba infections originate from direct contact of amoeba trophozoites 
with broken skin or from hematogenous dissemination derived from the respiratory tract 
or CNS [Marciano-Cabral and Cabral 2003]. Mortality from this infection has been 
reported to be 73% among individuals without Acanthamoeba CNS infection and 100% 
7 
among those with CNS involvement [Torno et al. 2000].  One symptom of this disease is 
the presence of draining non-healing skin ulcers.   Skin biopsy in concert with 
polymerase chain reaction (PCR), indirect immunofluorescence (IIF), and/or direct 
isolation of amoebae from tissue are current diagnostic tools used for diagnosing this 
infection.   Oral itraconazole, pentamidine, and 5-fluocytosine in concert with topical 
chlorhexidine gluconate and ketoconazole cream can be used to treat cutaneous 
acanthamoebiasis [Helton et al. 1993; Slater et al. 1994].  
GAE is a chronic and often fatal CNS disease.  GAE is most prevalent in immune 
compromised individuals [Marciano-Cabral and Cabral 2003].  Acanthamoeba that are 
known to cause GAE include A. culbertsoni, A. castellanii, A. astronyxis, A. polyphaga, 
A. healyi, and A. divionesis [Visvesvara et al. 2007]. Acanthamoeba trophozoites gain 
access to the CNS via two distinct routes: through the olfactory neuroepithelium or 
through hematogenous spread. However, it is believed that in human GAE trophozoites 
most often gain access to the CNS via hematogenous spread originating from the lungs or 
cutaneous infection [Marciano-Cabral and Cabral 2003; Khan 2008].  Specifically, it is 
believed that trophozoites from the blood enter the brain parenchyma via the capillary 
endothelium or the cerebral spinal fluid (CSF) via the endothelial cells of the choroid 
plexus [Khan 2007]. Once in the CNS, microglia and invading peripheral macrophages 
are the primary immune cells that interact with Acanthamoeba causing the release of pro-
inflammatory mediators [Marciano-Cabral and Cabral 2003]. GAE is characterized by 
the formation of granulomas (Figure 2); however, granulomas are rarely observed in  
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Figure 2: Characteristic Granuloma Associated with Granulomatous Amoebic 
Encephalitis (GAE). Hematoxylin and Eosin (H & E) stain of a GAE-associated 
granuloma illustrating hallmark infiltration of microglia and macrophages surrounding 
Acanthamoeba (arrow); bar designates 200 µm.  Courtesy of Dr. Francine Marciano-
Cabral, Ph.D.  
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immune compromised individuals [Martinez 1982]. Granulomas formed during GAE are 
composed of amoebae, microglia, macrophages, polymorphonuclear cells, T cells, and B 
cells [Marciano-Cabral and Cabral 2003; Khan 2008].   Granulomas have been 
demonstrated to be instrumental to slowing the progression of GAE as evidenced by the 
finding that immune suppression of Acanthamoeba infected mice, that is induced by 
treatment with the cannabinoid delta-9-tetrahydrocannabinol (Δ9-THC), results in an 
increased mortality rate as compared to control mice  [Marciano-Cabral et al. 2001].  The 
increase in mortality rate of Δ9-THC-mediated immune suppressed mice infected with 
Acanthamoeba was subsequently linked to a decreased presence of macrophages at focal 
sites of Acanthamoeba in the brain [Cabral and Marciano-Cabral, 2004].  Symptoms of 
GAE include nausea, vomiting, headache, stiff neck, seizures and lethargy [Marciano-
Cabral and Cabral 2003].  GAE is usually diagnosed upon autopsy.  The observation of 
brain lesions by Magnetic Resonance Imagery (MRI), observation of cysts by brain 
biopsy, and use of PCR have been the principal modes for diagnosis of GAE.   GAE is 
treated with a combination chemotherapeutics including oral itraconazole, pentamidine, 
sulfadiazine, fluconazole, and fluocytosine [Visvesvara et al. 2007].  Treatment can be 
successful if GAE is diagnosed early; however, in most cases prognosis is poor even in 
the presence of chemotherapeutics.  
Microglia and CNS invading peripheral macrophages are thought to be the 
primary cells that are responsible for mounting the immune response to invading 
Acanthamoeba.  Microglia, also known as “resident brain macrophages”, are one of four 
types of glial cells in the CNS; other glial cells include astrocytes, oligodendrocytes, and 
A 
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ependymal cells.  Microglia exist in various states of activation, as do macrophages.  
While in a resting state, microglia are in a ramified form in close association with 
astrocytes and are not capable of phagocytosis. Microglia respond to a variety of stimuli 
including cytokines such as interferon gamma (IFN)γ and TNF-α; and pathogen-derived 
components such as lipopolysaccharide (LPS). Once activated, microglia are capable of 
responding to sites of brain injury and can be characterized by their amoeboid shape, 
surface receptor expression, and chemokine/cytokine production. Additionally, reactive 
microglia are capable of migration to sites of damage via the chemokine/chemokine 
receptor network, phagocytosis that is promoted by TNF-α, and antigen presentation that 
is activated by IFNγ. 
Reactive microglia express a plethora of cell surface receptors including:  pattern 
recognition receptors for LPS (CD14/Toll receptor 4 (TLR4)) and mannose (mannose 
receptors); chemokine receptors CCR2, CCR3, CCR5, CXCR4, and CX3CR1; Fc 
receptors Fc RI, RII, RIII; cytokine receptors for IFNγ, TNF (TNF RI and RII), 
interleukin (IL)-1, and IL-12; and purinergic receptors [Vass and Lassmann et al. 1990; 
Peress et al. 1993; Ulvestad et al. 1994; Peterson et al. 1995; Becher and Antel 1996; 
Dopp et al. 1997; Harrison et al. 1998; Suzumura et al. 1998; Marzolo et al. 1999; 
McManus et al. 2000; Simpson et al. 2000; Aloisi 2001; Bsibsi et al. 2002; Ogata et al. 
2003; Rock et al. 2004]. Reactive microglia also are capable of producing and releasing a 
host of immune mediators. Some of these include the chemokines IL-8, regulated on 
activation, normal T-cell expressed and secreted (RANTES), macrophage inflammatory 
protein (MIP)-1 α//, MIP-2, interferon gamma-inducible 10kDa protein (IP-10), and 
11 
monocyte chemoattractant protein (MCP)-1; and pro-inflammatory cytokines IL-1α, IL-
1β, IL-6, IL-12, and TNF-α [Aloisi 2001; Ambrosini and Aloisi 2004; Rock et al., 2004].   
Studies have highlighted the role of microglia and CNS-invading peripheral 
macrophages as instrumental immune effector cells during GAE, contributing to the 
direct control of Acanthamoeba spread [Marciano-Cabral et al. 1998; Benedetto et al. 
2002; Benedetto et al. 2003; Marciano-Cabral et al. 2004].  It has been demonstrated that 
microglia elicit pro-inflammatory cytokines such as IL-1α, IL-1β, and TNF-α in response 
to Acanthamoeba [Marciano-Cabral et al. 2004, Shin et al. 2001].  Moreover, Marciano-
Cabral et al. [2004] demonstrated that highly pathogenic A. culbertsoni stimulates the 
secretion of higher levels of IL-1α, IL-1β, and TNF-α from primary rat microglia as 
compared to when these cells are stimulated with weakly pathogenic A. castellanii. 
However, reports indicate that such cytokines are not cytolytic to Acanthamoeba and, 
rather, may serve to activate microglial/macrophage cells for contact-dependent mediated 
killing of Acanthamoeba [Marciano-Cabral et al. 1998]. Activated macrophages have 
been reported to have an enhanced ability to phagocytose and kill Acanthamoeba 
[Marciano-Cabral et al. 1998; Alizadeh 2007].   In addition, microglia primed with IFN-γ 
plus IL-1β or TNF-α have been shown to be amoebastatic or amoebicidal against A. 
castellanii, respectively [Benedetto et al. 2002; Benedetto et al. 2003].   
 Acanthamoeba use both contact-dependent and contact-independent pathogenesis 
mechanisms [Khan 2006].  Contact-dependent pathogenesis mechanisms include 
adhesion to extracellular matrix proteins, binding to mannose sugars on host cells via 
mannose binding protein (MBP) expressed by Acanthamoeba trophozoites, and 
12 
phagocytosis of host cells [Khan 2006; Rocha-Azevedo et al. 2009]. Contact-independent 
pathogenesis mechanisms include the hydrolysis of ATP via ecto-ATPase expression and 
secretion of phospholipases and proteases [Khan 2006]. 
The first step to Acanthamoeba host invasion involves recognition of, and 
adhesion to, host tissue-expressed mannose and extracellular matrix proteins.  Recently, it 
has been demonstrated that highly pathogenic Acanthamoeba display differential 
adherence to extracellular matrix proteins with a preference for laminin-1 [Rocha-
Azevedo et al. 2009].  This adherence is thought to be attributed to an uncharacterized 55 
kDa membrane protein expressed by highly pathogenic Acanthamoeba [Rocha-Azevedo 
et al. 2009].  Studies have highlighted the role of Acanthamoeba MBP in binding corneal 
epithelial and human brain microvascular endothelial cells (HBMECs) [Morton et al. 
1991; Alsam et al. 2003].  Acanthamoeba binding is thought to induce host cell cycle 
arrest which may lead to apoptosis [Alizadeh et al. 1994; Shin et al. 2000; Sissons et al. 
2004b; Sissons et al. 2005]. Moreover, it has been demonstrated that damage to neurons 
and microglia occurs via contact-dependent mechanisms [Pettit et al. 1996; Marciano-
Cabral et al. 2000; Shin et al. 2000].  Acanthamoeba binding also has been linked to the 
induction of Acanthamoeba signal transductional pathways leading to increased protease 
secretion (discussed below) and activation of actin polymerization [Taylor et al. 1995; 
Hurt 2003b; Clarke and Niederkorn 2006b; Khan 2006].  Actin polymerization is 
instrumental to morphological changes that lead to phagocytosis of host cells.  
Phagocytosis serves as a food acquiring process for amoebae as evidenced by the 
presence of food cups during this event [Pettit et al. 1996].   
13 
One contact-independent pathogenesis mechanism used by Acanthamoeba is the 
hydrolysis of ATP by membrane ecto-ATPases (ecto-nucleotidases) [Sissons et al. 
2004a]. Ecto-ATPases belong to a group of enzymes known as ecto-enzymes that are 
characterized by the extracellular expression of their active sites [Sissons et al. 2004a; 
Goding 2000]  Ecto-ATPases hydrolyse adenosine triphosphate (ATP) to adenosine 
diphosphate (ADP) and adenosine monophosphate (AMP); and ADP to AMP [Goding 
2000]. It has been demonstrated that clinical isolates of Acanthamoeba express higher 
levels of ecto-ATPases than environmental isolates [Sissons et al. 2004a]. During 
Acanthamoeba infection hydrolyzed ATP in the form of ADP acts on host cell expressed 
P2Y2 purinergic receptors [Mattana et al. 2002].  This ADP activation has been 
demonstrated to induce TNF-α secretion, caspase 3 activation, and apoptosis of 
monocytic cells via P2Y2 receptors [Mattana et al. 2002].   Furthermore, ecto-ATPase 
activity increases in the presence of mannose, indicating that receptor activity is 
increased during host cell binding [Sissons et al. 2004a].    
Other contact-independent pathogenesis mechanisms used by Acanthamoeba 
include the production and secretion of phospholipases and proteases; of these, the 
production of proteases has been most widely studied.  It has been demonstrated that 
pathogenic Acanthamoeba secrete more phospholipase A than non-pathogenic 
Acanthamoeba [Cursons et al. 1978; Misra et al. 1983]. Pathogenic Acanthamoeba 
produce serine, cysteine, and metallo- proteases [He et al. 1990; Hadás et al. 1993a; 
Mitro et al. 1994; Mitra et al. 1995; Cao et al. 1998; Alfieri et al. 2000; Cho et al. 2000; 
Hong et al. 2000; Khan et al. 2000; Kong et al. 2000; Na et al. 2001; Hong et al. 2002; 
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Na et al. 2002; Alsam et al. 2005; Kim et al. 2006; Sissons et al. 2006]. However, serine 
proteases represent the major class of proteases secreted by Acanthamoeba [Khan 2006].  
Serine proteases constitute a class of enzymes that have the amino acid serine 
located in their active site and are able to cleave peptide bonds.  Highly virulent 
Acanthamoeba have been demonstrated to secrete higher levels of proteases than less 
virulent Acanthamoeba [Hadás et al. 1993b; Khan et al. 2000]. In Acanthamoeba’s 
natural environment, serine proteases are thought to play a key role in encystment and 
excystment [Moon et al. 2008; Dudley et al. 2008].  Acanthamoeba serine proteases also 
are believed to facilitate invasion and evasion within the infected host.   
Many studies have linked Acanthamoeba serine proteases to host invasion.  
Acanthamoeba serine proteases have been demonstrated to degrade ECM components 
such as collagen, laminin, elastin [Kong et al. 2000; Na et al. 2001; Na et al. 2002; Hurt 
et al. 2003a; Sissons et al. 2006].  In addition, Acanthamoeba binding to corneal 
epithelial cells via MBP has been shown to increase the expression of a 133kDa 
Acanthamoeba serine protease called mannose-induced protease (MIP-133); and, 
subsequent studies found this protease to be cytolytic to these cells [Hurt et al. 2003a and 
Hurt et al. 2003b]. Using an in vitro blood-brain barrier (BBB) model, Alsam et al. 
[2003] demonstrated that, although Acanthamoeba binding to HBMECs can be blocked 
in vitro with exogenous mannose, HBMEC cell cytotoxicity increased in the presence of 
exogenous mannose.  Subsequent studies demonstrated that conditioned medium from A. 
castellanii increased BBB permeability and that this effect was prevented in the presence 
of the serine protease inhibitor phenylmethylsulphonylfluoride (PMSF) [Alsam et al. 
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2005].  Moreover, it has been demonstrated that conditioned medium from 
Acanthamoeba degrades zonula occludens 1 (ZO-1) and occludin tight junction proteins 
of HBMEC monolayers; this action is believed to be mediated by Acanthamoeba serine 
proteases [Khan 2007].   
Acanthamoeba serine proteases also have been implicated as having a functional 
role in evasion of host cell defenses.  Previous studies have indicated that Acanthamoeba 
serine proteases are able to degrade the immunoglobulins secretory IgA (sIgA), IgG, 
IgM; the cytokines IL-1α and IL-1β; and other proteins such as plasminogen, 
hemoglobin, fibrinogen, and albumin [Kong et al. 2000; Na et al. 2001; Na et al. 2002; 
Sissons et al. 2006]. However, all of these studies were performed using exogenous 
substrates (i.e., recombinant protein substrates) and, though they give important insight to 
the potential functional role of serine proteases in host immune evasion, there is still a 
paucity of information with regards to how Acanthamoeba specifically use their serine 
proteases for immune evasion. 
The goal of the present study was to determine the functional relevance of A. 
culbertsoni-elicited serine proteases in CNS immune evasion.  We hypothesized that 
serine proteases provide an effective means of host immune evasion for Acanthamoeba 
by dampening microglial immune response through the degradation of elicited cytokines 
and chemokines.  In order to test our hypothesis we proposed four specific aims: i) to 
characterize proteases elicited by A. culbertsoni, ii) to determine the cytokine and 
chemokine profile elicited by microglial-like cells in response to A. culbertsoni, iii) to 
determine if A. culbertsoni-elicited factors could degrade constitutive and LPS-stimulated 
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cytokines and chemokines produced by microglial-like cells, and iv) to determine if pro-
inflammatory cytokines and chemokines elicited by microglial-like cells in the presence 
A. culbertsoni could be degraded by A. culbertsoni serine proteases.   
We demonstrate that A. culbertsoni secrete serine proteases, the levels of which 
are augmented in the presence of microglial-like cells.  A. culbertsoni induced the gene 
expression of a plethora of pro-inflammatory cytokines and chemokines by microglial-
like cells as assessed by Multiprobe Ribonuclease Protection Assay (RPA) and 
cytokine/chemokine protein microarrray.  However, we demonstrate that the cytokines 
and chemokines elicited from microglial-like cells were degraded by A. culbertsoni serine 
proteases.  While it is likely that A. culbertsoni use a multifactorial process to elicit 
pathogenesis during GAE, these studies suggest that A. culbertsoni serine proteases aid in 
A. culbertsoni CNS immune evasion by specifically targeting microglial facilitated 
granuloma formation and anti-microbial activity.   
 17 
 
 
 
Materials and Methods 
 
Reagents.  Dulbecco’s Modified Eagle’s Medium (DMEM; with phenol red, without L-
glutamine), 100X penicillin/streptomycin, 1M HEPES, 100X nonessential amino acids 
(NEAA), 200 mM L-glutamine, and 100X Modified Eagle’s Medium (MEM) vitamins 
were purchased from Cellgro/Mediatech, Inc. (Herndon, VA).  Fetal Bovine Serum 
(FBS) and heat-inactivated (HI) FBS were purchased from both Cellgro/Mediatech, Inc. 
and KSE Scientific (Durham, NC).  Neurobasal™-A medium (without phenol red), B-27 
supplement, 1X phosphate buffered saline (PBS; without MgCl2 and CaCl2; pH 7.4), and 
TRIzol
® 
reagent were purchased from Invitrogen (Carlsbad, CA).  Lipopolysaccharide 
(LPS), phenylmethylsulphonylfluoride (PMSF), trans-Epoxysuccinyl-L-leucylamido(4-
guanidino)butane (E-64), and glucose were purchased from Sigma-Aldrich (St. Louis, 
MO).  HyClone
®
 100X penicillin G/streptomycin/amphotericin B, Remel oxoid 
neutralized liver digest, and Remel proteose peptone were purchased from Thermo Fisher 
Scientific (Lenexa, KS).  Bacto™ yeast extract was purchased from Becton, Dickinson 
and Company (Franklin Lakes, NJ). Dextrose was purchased from J.T. Baker Chemicals 
(Phillipsburg, NJ).  
Amoebae. Acanthamoeba culbertsoni (ATCC # 30171) were acquired from the 
American Type Culture Collection (ATCC, Manassas, VA). Axenic (i.e., culture free of 
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other contaminating microorganisms) amoebae were maintained either in oxoid medium 
(0.55% w/v oxoid neutralized liver digest, 0.3% w/v dextrose, 0.5% w/v proteose 
peptone, 0.25% w/v yeast extract, 1% FBS, and 0.1% hemin) or proteose peptone, yeast, 
glucose (PYG) medium (2% w/v proteose peptone, 0.2% w/v yeast extract, and 0.1M 
glucose) at 37ºC.  
Microglia.  Immortalized primary mouse microglial-like BV-2 cells were a gift from Dr. 
Michael McKinney of the Mayo Clinic (Jacksonville, FL).  BV-2 cells were maintained 
in complete DMEM (i.e., DMEM supplemented with 10% HI-FBS, 100 U/ml penicillin 
G, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B, 0.01M HEPES, 1X NEAA, 
2mM L-glutamine, and 1X MEM vitamins) at 37ºC with 5% CO2.   
Conditioned Medium. Microglial conditioned medium (MCM) was generated by 
culturing 10
6
 BV-2 cells in T25 cm
2
 (Greiner, Monroe, NC) tissue culture flasks in 
complete DMEM overnight at 37ºC with 5% CO2.   The following day, cultures were 
washed with sterile PBS and 5ml complete Neurobasal™-A medium (serum free, 
supplemented with 1X B-27 supplement, 100 U/ml penicillin, 100 µg/ml streptomycin, 
and 0.5 mM L-glutamine) were added.  Neurobasal™-A medium is specifically 
formulated to mimic the serum-free environment of the brain.   Cells were cultured an 
additional 9-24 h at 37ºC with 5% CO2.   The supernatant (i.e., conditioned medium) was 
collected by centrifugation at 1700 x g for 10 min at 4°C. Conditioned medium from LPS 
stimulated BV-2 cells was generated in a similar manner except that BV-2 cells were 
initially cultured overnight in 60 mm x 15 mm petri dishes at 37ºC with 5% CO2.  Cells 
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were washed with PBS, complete Neurobasal™-A medium (CNBA) containing 100 
ng/ml LPS was added, and cultures were incubated 8 h at 37ºC with 5% CO2.   
Supernatants (LPS/MCM) were collected by centrifugation (1700 x g, 10 min, 4°C) and 
stored at -80°C until assayed for cytokines and chemokines. 
Acanthamoeba culbertsoni conditioned medium (ACM) was generated from 
cultures of 10
9
 A. culbertsoni (ACM-HI) and 10
6
 A. culbertsoni (ACM-LO).  For 
generation of ACM-HI, axenic A. culbertsoni were cultured in Erlenmeyer flasks 
containing 1L oxoid or PYG medium at 37ºC with shaking for 4 days to yield 
approximately 10
9
 amoebae.  The amoebae were pelleted by centrifugation at 6090 x g 
for 20 min at 4°C, 5ml CNBA were added to the pellet and the pellet was incubated at 
37ºC for 24 h.  The amoebae were re-pelleted by centrifugation (1700 x g, 10 min, 4°C).  
The supernatant (i.e., conditioned medium) was removed and centrifuged at (1700 x g, 10 
min, 4°C) to remove debris, and the conditioned medium (i.e., supernatant) was stored at 
-80ºC until used in experiments. The protein concentration of ACM-HI was determined 
by the Bradford method [1976], dilutions of this conditioned medium were used in select 
experiments.  ACM-LO was prepared by incubating 10
6 
axenic A. culbertsoni, which was 
originally propagated in oxoid medium, in 5ml CNBA in T25 cm
2 
flasks at 37ºC with 5% 
CO2 for 24 h.  The supernatant was then removed, centrifuged (1700 x g, 10 min, 4°C) 
and stored -80ºC.  
Conditioned medium from co-cultures of BV-2 cells and A. culbertsoni 
(MCM/ACM) was generated by first culturing 10
6
 BV-2 cells in complete DMEM in T25 
cm
2
 flasks overnight at 37ºC with 5% CO2.  The next day, the cells were washed with 
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PBS, CNBA was added, and 10
6
 A. culbertsoni (originally propagated in oxoid medium) 
was added to the BV-2 cell cultures. Co-cultures were incubated at 37ºC with 5% CO2 for  
9-24 h.  Culture supernatants were then harvested by centrifugation at (1700 x g, 10 min, 
4°C) and stored at -80ºC.   
Two-Dimensional (Iso-Dalt) Gel Electrophoresis (2D-PAGE). Two-dimensional (Iso-
Dalt) gel electrophoresis was used to separate proteins in CNBA (background control) 
and ACM.  Briefly, amoebae were cultured in Erlenmeyer flasks containing 1L PYG 
medium at 37ºC with shaking for 4 days to yield approximately 10
9
 amoebae.  The 
amoebae were pelleted by centrifugation at 6090 x g for 20 min at 4°C, 5ml CNBA were 
added to the pellet and the pellet was incubated at 37ºC for 24 h.  The amoebae were re-
pelleted by centrifugation (1700 x g, 10 min, 4°C).  The supernatant (i.e., conditioned 
medium) was removed and centrifuged at (1700 x g, 10 min, 4°C) to remove debris, and 
the conditioned medium (i.e., supernatant) was stored at -80ºC until used in experiments. 
In order to remove interfering salts before performing the isoelectric focusing first-
dimension, samples were dialyzed overnight against ultrapure deionized water using 
Slide-A-Lyzer 3.5K molecular weight cutoff dialysis cassettes (Pierce Biotechnology, 
Inc, Rockford, IL).  Protein concentrations were determined by the Bradford method 
[Bradford, 1976] and 500g of CNBA protein and 1000g of ACM protein were added 
to ReadyPrep
TM
 rehydration/sample buffer (8 M urea, 2% CHAPS, 50 mM DTT, 0.2% 
Bio-Lyte
® 
3/10 ampholyte, and trace bromophenol blue) (Bio-Rad, Hercules, CA) in a 
total volume of 200 μl. A carbonic anhydrase carbamylated isoelectric point marker 
(20l) (GE Healthcare, Piscataway, NJ) was added to the CNBA protein sample before 
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performing first dimension isoelectric focusing.  The protein samples were applied to 
ReadyStrip
TM
 IPG pH 3-10 (Bio-Rad) strips that had been previously rehydrated with 
ReadyPrep
TM
 rehydration/sample buffer overnight at room temperature.  The samples 
were allowed to passively rehydrate for 2 h at room temperature. The proteins were 
isoeletrically focused for 45,900 and 59,000 volt hours for CNBA and ACM, 
respectively, using a PROTEAN
®
 IEF cell (Bio-Rad). Electrophoresis in the second 
dimension was performed in 10-20% gradient SDS-PAGE gels using the Criterion
TM
 gel 
electrophoresis system (Bio-Rad). The gels were stained with Bio-Safe
TM
 Coomassie 
Blue G-250 (Bio-Rad).  Gels were scanned on a Microtek ScanMaker 9800XL/TMA 
1600 flatbed scanner (Microtek, Santa Monica, CA) interfaced with a Compaq computer 
(Hewlett-Packard Company, Houston, TX) using SilverFast scanning software. 
 
Gel Zymography.   Gel zymography was performed to measure protease activity in 
conditioned media.  Briefly, 10μl 2X Novex® tris-glycine SDS sample buffer (Invitrogen) 
were added to each 10μl sample prior to loading. In select experiments, samples were 
incubated (37ºC for 30 min.) with PMSF and E-64 prior to electrophoresis in order to 
assess for serine and cysteine protease activity, respectively. Samples were loaded into 
pre-cast Novex
®
 10% gelatin zymogram gels (Invitrogen) and gels were electrophoresed 
(125V, 90 min) in Novex
® 
tris-glycine SDS buffer. Following electrophoresis gels were 
incubated (30 min, room temperature) in 1X Novex
® 
zymogram
 
renaturing buffer 
(Invitrogen) with gentle rocking, and then equilibrated (30 min, room temperature) in 1X 
Novex
®
 zymogram developing buffer, pH 7.5 (Invitrogen) with gentle rocking.  
Following the addition of fresh 1X Novex
®
 zymogram developing buffer, pH 7.5, gels 
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were incubated at 37ºC overnight.  Protease digestion was viewed as areas of clearing on 
a blue background following staining with SimplyBlue™ Safestain (Invitrogen). Gels 
were scanned on a Microtek ScanMaker 9800XL/TMA 1600 flatbed scanner interfaced 
with a Compaq computer using SilverFast scanning software. 
 
Light Microscopy. Light microscopy images of BV-2 cell cultures, A. culbertsoni 
cultures, and BV-2/ A. culbertsoni co-cultures were acquired using an Olympus CK2 
inverted microscope (Opelco, Washington, DC) in concert with an attached XV-GP230 
digital video camera (Panasonic, Yokohoma, Japan). A Dell Dimension XPS1450 
computer (Dell, Inc., Round Rock, Texas) programmed with Videum 100 hardware and 
Window NT software (Winnov, Sunnyvale, CA) was used to capture images. 
Multiprobe Ribonuclease Protection Assay (RPA). BV-2 cells (1.5 x 10
6
) were co-
cultured (6 h) with A. culbertsoni in 60 mm culture dishes at 37
o
C with 5% CO2. Total 
RNA was prepared from cell cultures using TRIzol
® 
reagent (Invitrogen) according to the 
manufacturer’s instructions, subjected to isopropanol precipitation, and dissolved directly 
in 1X hybridization buffer (BD Biosciences/PharMingen, San Diego, CA).  A Riboquant 
RPA was used to assess for levels of mouse chemokine mRNA (mCK-5c probe template 
set; BD Biosciences/PharMingen). The ribo-probes were labeled with 
32
P [UTP] (MP 
Biomedicals, Aurora, OH) to a specific activity of greater than 3,000 Ci/mmol.  The 
isolated RNA samples then were hybridized with the probe overnight at 56
o
C and the 
protected fragments were resolved on a 6% polyacrylamide gel containing 6M urea.  
Imaging of the protected fragments was performed using a 445 SI Phosphorimager 
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(Molecular Dynamics, Sunnyvale, CA).  The pixel intensity of each band was quantified 
using ImageQuant 4.1 software (Molecular Dynamics) and the amount of chemokine 
mRNA was normalized for loading by dividing the pixel value for the chemokine 
expression band by the sum of the pixel values for the mRNAs of the housekeeping 
genes, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and a ribosomal protein, 
L32.  
 
Cytokine/Chemokine Protein Microarray.  The RayBio
®
 Mouse Cytokine Antibody 
Array III (RayBiotech, Inc., Norcross GA) was used as a semi-quantitative measure of 
cytokines and chemokines in culture supernatants according to the manufacturer’s 
instructions.  Briefly, arrays were blocked (30 min, room temperature) in manufacturer 
supplied blocking buffer.  After blocking, 1ml of culture supernatant was added. 
Following incubation overnight at 4°C, the membranes were washed with manufacturer 
provided wash buffers and incubated (1.5 h) with biotin-conjugated anti-cytokine 
antibodies.  After washing to remove unbound biotin-conjugated anti-cytokine 
antibodies, the membranes were incubated (2 h) with horseradish peroxidase (HRPO)-
conjugated strepavidin, washed, and protein was visualized by chemilumenescent 
reaction in concert with a Kodak X-OMAT 2000A processing instrument (Kodak, 
Rochester, NY) and Kodak BioMAX XAR film.  Film was scanned on a Microtek 
ScanMaker 9800XL/TMA1600 flatbed scanner and densitometry was performed using 
Quantity One
®
 software (Bio-Rad, Hercules, CA).  
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Enzyme-linked Immunosorbent Assay (ELISA).   BV-2 cells were co-cultured with A. 
culbertsoni for 9-24 h (37ºC with 5% CO2), culture supernatant (MCM/ACM) was 
collected and incubated (37ºC with 5% CO2) an additional 12-48 h.   DuoSet mouse 
sandwich ELISA kits (R & D Systems, Inc., Minneapolis, MN) were used to quantify 
levels of TNF-α, MIP-1α, and MIP-2 in MCM/ACM samples.  For ELISA, Corning 
Costar

 EIA plates (Corning, Inc., Lowell, MA) were coated with 0.8 µg/ml goat anti-
mouse TNF-α, 0.4 µg/mL goat anti-mouse MIP-1α, or 2.0 g/ml rat anti-mouse MIP-2, 
incubated overnight at room temperature, washed (0.05% Tween-20 in PBS, pH 7.4), and 
blocked (1 h) with reagent diluent (1% BSA in PBS, pH 7.4, 0.2 m filtered).  Following 
addition of samples or standards (100 µl), plates were incubated (2 h) at room 
temperature, washed, and incubated (2 h, room temperature) with 150 ng/ml biotinylated 
goat anti-mouse TNF-α, 100 ng/ml biotinylated goat anti-mouse MIP-1α, or 75 ng/ml 
biotinylated goat anti-mouse MIP-2.   The plates then were washed, and streptavidin 
conjugated HPRO was added. Following incubation (20 min, room temperature) a 1:1 
mixture of manufacturer provided substrate reagent (H2O2 and Tetramethylbenzidine 
(TMB)) was added (20 min, room temperature).  After addition of stop solution (2 N 
H2SO4), the optical density of each sample was determined using a SpectraMax 250 
spectrophotometer (MDS Analytical Technologies, Sunnyvale, CA) in concert with 
SoftMax Pro software (MDS Analytical Technologies). All wells were read at 450nm 
with a correction wavelength of 570nm.  Standards consisted of two-fold dilutions of 
recombinant mouse TNF-α (2000 pg/ml to 31.25 pg/ml), MIP-1α (500 pg/ml to 7.81 
pg/ml), or MIP-2 (1000 pg/ml to 15.63 pg/ml).   
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Data Analysis.  For cytokine/chemokine protein microarrays, background was subtracted 
and the density of duplicate cytokine and chemokine array spots (i.e., the sum of pixels 
per array spot), which corresponded to the relative amount of cytokines or chemokines in 
each supernatant sample, was normalized to the average density of the standards (i.e., 
internal positive controls consisting of biotin-conjugated IgG) included in each 
membrane.  Density values were graphed as the mean value intensity and a fold 
difference of > 2.1 as compared to control was considered significant.  Error bars 
represent the + S.D. of duplicate cytokine or chemokine spots.  For ELISA, the percent 
maximum response was calculated by comparing the optical density of samples that were 
incubated for an additional 12-48 h to optical density of the starting co-culture 
supernatant (i.e., 9 h or 24 h co-culture supernatant); the optical density of the co-culture 
supernatant at 9 h or 24 h was considered the 100% value.  Samples were performed in 
triplicate and the average optical density of each sample was used to calculate percent 
maximum response.  
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Results 
 
 
Acanthamoeba culbertsoni Secrete Degradative Enzymes. 
 
Two-dimensional (iso-dalt) gel electrophoresis (2D-PAGE) was used to visualize 
and compare proteins of CNBA versus ACM.  For this study, supernatant form A. 
culbertsoni (i.e., ACM) was generated from 10
9 
amoebae which were propagated in PYG 
medium, pelleted, and incubated in the presence of CNBA; the resulting supernatant was 
designated as ACM-HI. The proteomic profile of CNBA revealed a large protein spot at 
the approximate molecular weight (kDa) of 62, which is consistent with the approximate 
molecular weight predicted for albumin (Figure 3).  A carbonic anhydrase pI marker, 
which was included as an internal standard within the CNBA two-dimensional gel, had a 
molecular weight of 26 kDa and a pI range approximately 4.8-6.7 (Figure 3).  ACM-HI 
exhibited a proteomic profile that was distinct from that of CNBA (Figure 4).  Notably, 
the ACM-HI proteomic profile displayed a complete absence of the 62 kDa albumin spot 
(Figure 4).   These results are consistent with the presence of A. culbertsoni degradative 
enzymes in ACM-HI. 
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Figure 3: Visualization of Complete Neurobasal-A Medium Proteins.  Complete 
Neurobasal-A Medium proteins (500 µg) were separated based on relative charge (pI) 
(pH 3-10) in the first dimension and relative molecular weight in the second dimension 
(10-20% SDS-PAGE).  Proteins were visualized using Coomassie G-250 protein stain.   
The top arrow indicates a major protein spot at 62 kDa.  The bottom arrow indicates a 
carbonic anhydrase pI marker at 26 kDa and pI range of ~ 4.8-6.7 that was included as an 
internal standard.  Complete Neurobasal-A Medium was used to generate conditioned 
medium from BV-2 cell cultures, A. culbertsoni cultures, and BV-2 cell plus A. 
culbertsoni co-cultures.    
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Figure 4: Visualization of A. culbertsoni-Conditioned Medium Proteins.  
Acanthamoeba culbertsoni conditioned medium (ACM) was generated from 
approximately 10
9 
amoebae (i.e., ACM-HI) which were propagated in proteose peptone, 
yeast, glucose (PYG) medium.  Following propagation, amoebae were pelleted and 
incubated in the presence of complete Neurobasal™-A medium (24 h).  Supernatant (i.e., 
conditioned medium) was harvested and proteins (1000 g) were separated based on 
relative charge (pI) (pH 3-10) in the first dimension and relative molecular weight in the 
second dimension (10-20% SDS-PAGE). Following electrophoresis, proteins were 
visualized using Coomassie G-250 protein stain.    
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Acanthamoeba culbertsoni Secrete Serine Proteases.  
 
Gelatin zymography was employed in order to determine whether differences in 
the two-dimensional (iso-dalt) gel electrophoresis proteomic profiles of CNBA versus 
ACM-HI were attributed to the presence of A. culbertsoni protease activity. Gelatin 
zymography is a technique that allows for the detection of serine, cysteine, and metallo-
proteases.  Initially, the proteolytic profiles of ACM-HI generated from amoebae 
propagated in either oxoid or PYG medium were compared (Figure 5).  Acanthamoeba 
culbertsoni propagated in oxoid or PYG medium exhibited three common protease bands 
of approximately 187, 97, and 58 kDa (Figure 5).  Propagation of A. culbertsoni in oxoid 
medium resulted in protease activity that was more robust as compared to amoebae 
propagated in PYG medium.  CNBA did not show evidence of protease activity (Figure 
5).  These results indicate that components of the oxoid medium influence A. culbertsoni 
protease levels.  Oxoid medium was used to propagate amoebae in all subsequent 
experiments.   
  Titration of ACM-HI revealed protease activity at positions corresponding to 
187, 97, 90, and 58 kDa (Figure 6).  Protease activity located at positions corresponding 
187 and 58 kDa were the most robust.  Protease activity located at positions 
corresponding to 97 and 90 kDa was significantly reduced at 0.5 µg as compared to the 
starting concentration at 1.5 µg (Figure 6).   
 Protease inhibitors in concert with gelatin zymography were used to identify the 
class of proteases secreted by A. culbertsoni.  Initially, ACM-HI (1.0 µg) was incubated 
with either the serine protease inhibitor PMSF (2.0-0.125 mM) or anhydrous ethanol  
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Figure 5: A Comparison of the Effect of Propagation Medium on A. culbertsoni 
Protease Activity.  A. culbertsoni (10
9
) were propagated in either oxoid (OX) or PYG 
media. Then amoebae were pelleted and cultured in the presence of complete 
Neurobasal™-A medium (background control, C) for 24 h.  Supernatants (i.e., A. 
culbertsoni-conditioned medium; ACM) were collected and 1.0 µg of ACM protein was 
assessed by gelatin zymography.  Arrows indicate protease activity at positions 
corresponding to 187, 97, and 58 kDa.  Relative molecular weight was calculated on the 
basis of the mean center point for each respective band on gelatin zymograms. 
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Figure 6: Titration of Protease Activity in 10
9
 A. culbertsoni-Conditioned Medium. 
The protease activity of 1.5-0.25 µg of 10
9
 A. culbertsoni-conditioned medium (ACM-
HI) was assessed by gelatin zymography.   Arrows indicate protease activity at positions 
corresponding to 187, 97, 90, and 58 kDa.  Relative molecular weight was calculated on 
the basis of the mean center point for each respective band on gelatin zymograms. 
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(PMSF vehicle) (Figure 7).  All ACM-HI protease activity was sensitive to PMSF 
indicating that A. culbertsoni secrete serine proteases (Figure 7). The PMSF vehicle did 
not have an effect on protease activity.   Specifically, ACM-HI serine protease activity 
was completely inhibited by PMSF at concentrations as low as 1.0 mM.  As expected, 
lower concentrations of PMSF (i.e., 0.500-0.125 mM) resulted in slight recovery of 
protease activity at 187 kDa.  Based on these results, 1.0 mM PMSF was used in all 
subsequent experiments requiring the use of protease inhibitors.  ACM-HI (0.75 µg) was 
also incubated with the cysteine protease inhibitor E-64 (10-1 µM) at pH 7.5 (Figure 8). 
Gelatin zymogram studies were also performed on ACM-HI (1.0 µg) which was 
incubated in the presence of 10 µM E-64 at pH 5.0 (data not shown).  Gelatin 
zymography revealed that ACM-HI protease activity was not sensitive to E-64 (Figure 8 
and data not shown).  This result suggests that A. culbertsoni cysteine protease activity 
was not detectable under the experimental conditions used. 
 Protease activity in ACM-HI, conditioned medium from 10
6
 amoebae (ACM-
LO), and conditioned medium from co-cultures of BV-2 cells (mouse microglial-like 
cells) plus A. culbertsoni (MCM/ACM) were compared using gelatin zymography.  
ACM-HI, ACM-LO, and MCM/ACM exhibited three common protease bands 
corresponding to 187, 97, and 58 kDa (Figure 9).  In addition, all protease bands were 
serine proteases as evidenced by their sensitivity to PMSF.  The similarities in protease 
activity from ACM-LO and MCM/ACM indicate that co-culture of A. culbertsoni with 
BV-2 cells did not elicit differential patterns of protease expression.  However, an overall 
increase in protease activity was observed in MCM/ACM as compared to ACM-LO, 
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Figure 7: Acanthamoeba culbertsoni Secrete Proteases that Are Inhibited by the 
Serine Protease Inhibitor Phenylmethylsulphonylfluoride (PMSF).  Conditioned 
medium (ACM-HI) (1.0 µg) from 10
9
 A. culbertsoni was subjected to no treatment (0),  
incubated (30 min, 37°C) in the presence of 5% anhydrous ethanol that served as the 
vehicle (V) for PMSF, or incubated (30 min, 37°C) in the presence of the serine protease 
inhibitor PMSF (2.0-0.125 mM).  Arrows indicate protease activity at positions 
corresponding to 187, 97, 90, and 58 kDa.  Relative molecular weight was approximated 
based on comparable gelatin zymograms. 
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Figure 8: Acanthamoeba culbertsoni Secrete Proteases that Are Not Inhibited by the 
Cysteine Protease Inhibitor trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane 
(E-64).  10
9
 A. culbertsoni-conditioned medium (ACM-HI) (0.75 µg) was subjected to no 
treatment (0) or incubated (30 min, 37°C) in the presence of the cysteine protease 
inhibitor E-64 (10-1 µM).  Arrows indicate protease activity at positions corresponding to 
187, 97, 90, and 58 kDa. Relative molecular weight was calculated on the basis of the 
mean center point for each respective band on gelatin zymograms. 
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Figure 9: A Comparison of the Proteolytic Activity in Three Different Types of A. 
culbertsoni-Conditioned Media. Equal volumes of 10
9
 A. culbertsoni-conditioned 
medium (ACM-HI), 10
6
 A. culbertsoni-conditioned medium (ACM-LO), and conditioned 
medium from co-culture of 10
6
 A. culbertsoni plus 10
6
 BV-2 cells (MCM/ACM) were 
subjected to no treatment (0), incubated (30 min, 37°C) in the presence of 5% anhydrous 
ethanol that served as the vehicle (V) for PMSF, or incubated (30 min, 37°C) in the 
presence of the serine protease inhibitor PMSF (P) (1.0 mM), and protease activity was 
assessed using gelatin zymography.  Arrows indicate protease activity at positions 
corresponding to 187, 97, and 58 kDa. Relative molecular weight was calculated on the 
basis of the mean center point for each respective band on gelatin zymograms. 
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indicating that co-culture of A. culbertsoni with microglial-like cells augments A. 
culbertsoni protease activity. 
Gelatin zymography also was used to compare protease activity in ACM-LO and 
MCM/ACM from 9-24 h cultures (Figure 10).   Protease activity in ACM-LO and 
MCM/ACM from 9 h culture was less intense as compared to the protease activity at 24 
h, indicating a time-related accumulation of A. culbertsoni proteases in culture 
supernatant.  Protease activity in MCM/ACM was more intense than that of ACM-LO at 
all time points studied, indicating that co-culture with BV-2 cells augments A. culbertsoni 
protease activity (Figure 10). 
 
Acanthamoeba culbertsoni Stimulate Microglial-Like Cells to Produce and Secrete 
Cytokines and Chemokines.  
 In order to determine whether BV-2 cells were inducibly responsive to A. 
culbertsoni in terms of expressing chemokines, BV-2 cells were co-cultured (6 h) with A. 
culbertsoni and the levels of select chemokine mRNAs were evaluated by RPA (Figure 
11).  BV-2 cells maintained in the absence of A. culbertsoni did not elicit discernable 
levels of chemokine mRNAs.  In contrast, A. culbertsoni stimulated BV-2 cells to 
produce mRNAs for monocyte chemoattractant protein (MCP)-1, interferon gamma-
inducible 10kDa protein (IP-10), macrophage inflammatory protein (MIP)-2, MIP-1α, 
and MIP-1β. Of these, the most robust induction levels were those for MIP-1α.  
Acanthamoeba did not express mRNAs for cytokines nor internal controls included in the 
RPA (data not shown). 
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Figure 10: Acanthamoeba culbertsoni-Conditioned Medium Proteolytic Activity 
Increases in a Time-Related Manner and Is Augmented During Co-culture With 
BV-2 Cells.  The proteolytic activity of conditioned medium from 10
6
 A. culbertsoni 
(ACM-LO) and conditioned medium from co-culture of 10
6
 A. culbertsoni plus 10
6
 BV-2 
cells (MCM/ACM) (9-24 h cultures) was assessed by gelatin zymography.  ACM-LO is 
labeled “A” and MCM/ACM is labeled “M/A”.  Arrows indicate protease activity located 
at positions corresponding to 187, 97, and 58 kDa. Relative molecular weight was 
calculated on the basis of the mean center point for each respective band on gelatin 
zymograms. 
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Figure 11: Acanthamoeba culbertsoni Induces Chemokine mRNA Expression by BV-
2 Cells.  A Multiprobe Ribonuclease Protection (RPA) assay was used to measure 
chemokine mRNA expression by BV-2 cells following co-culture (6 h) with A. 
culbertsoni.  (A) RPA: lanes labeled “P” represent the undigested probes for LTN, 
RANTES, MIP-1α, MIP-1β, MIP-2, IP-10, MCP-1, TCA-3, Eotaxin and the 
constitutively expressed internal controls L32 and GAPDH. Lanes labeled “M + A” and 
“M” represent samples from BV-2 cells plus A. culbertsoni and BV-2 cells alone, 
respectively.  (B) Graphical depiction of RPA results.  Courtesy of Dr. Erinn Raborn, 
Ph.D. 
A 
B 
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In order to determine the profile of cytokines/chemokines at the protein level that 
were elicited in response to A. culbertsoni, culture supernatants from BV-2 cell cultures 
maintained in the absence (MCM) or presence of A. culbertsoni (MCM/ACM) (9-24 h) 
were examined using cytokine/chemokine protein microarray (Figures 12 and 13).  A 9 
h period post co-culture was selected for assessment since it represents a 3 h differential 
time interval post assessment of mRNA elicitation and thereby putatively allowed for the 
production of a protein product (Figure 12).   A 24 h period post co-culture time was 
selected in order to assess time-related differences in cytokine and chemokine expression 
as compared to 9 h culture supernatants (Figure 13).    BV-2 cell cultures maintained (9 
h) in the absence of A. culbertsoni constitutively expressed relatively high levels of MCP-
1, MIP-1α, and MIP-1γ as well as moderate levels of MIP-2, platelet factor 4 (PF-4), P-
Selectin, soluble tumor necrosis factor receptor (sTNF R) I and sTNF RII (Figure 12).    
BV-2 cells maintained (9 h) in co-culture with A. culbertsoni expressed decreased levels 
of MIP-1α (2.1 fold decrease), MIP-1γ (2.1 fold decrease), PF-4 (2.3 fold decrease), 
sTNF RI (3.4 fold decrease), and sTNF RII (2.6 fold decrease) (Figure 12).  There was 
also a decrease in MCP-1 levels (2.0 fold decrease) observed in supernatants from co-
cultures of BV-2 cells and A. culbertsoni (Figure 12).  However, augmented levels of 
granulocyte-colony stimulating factor (G-CSF) (2.3 fold increase), IL-12p40/70 (2.5 fold 
increase), TNF-α (2.6 fold increase), and MIP-3α (4.1 fold increase) were observed from 
co-culture supernatants as compared to supernatants for BV-2 cell cultures maintained in 
the absence of A. culbertsoni for 9 h (Figure 12).  There was also an increase in IL-1α 
levels (1.5 fold increase) observed in supernatants from co-cultures of BV-2 cells and 
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Figure 12: Cytokine and Chemokine Protein Expression by BV-2 Cells following 9 h 
Co-culture with A. culbertsoni. The RayBio
®
 Mouse Cytokine Antibody Array III 
arrays were used to screen for cytokines and chemokines in supernatants from BV-2 cell 
culture (9 h, MCM) and BV-2 cell plus A. culbertsoni co-culture (9 h, MCM/ACM).  (A) 
Membrane arrays comparing cytokine and chemokine proteins of MCM versus 
MCM/ACM. (B) Graphical depiction of select cytokines and chemokines in MCM versus 
MCM/ACM.  The relative amount of each cytokine and chemokine was normalized using 
the average density of the standards (Std.) represented in each membrane.  Cytokines and 
chemokines are labeled: (1) G-CSF, (2) IL-1α, (3) IL-1β, (4) IL-12p40/70, (5) MCP-1, 
(6) MIP-1α, (7) MIP-1γ, (8) MIP-2, (9) MIP-3β, (10) MIP-3α, (11) PF-4, (12) P-Selectin, 
(13) RANTES, (14) TNF-α, (15) sTNF RI, and (16) sTNF RII.  * indicates a ≥ 2.1 fold 
increase as compared to MCM, + indicates a ≥ 2.1 fold decrease as compared to MCM.  
 
B 
A 
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Figure 13: Cytokine and Chemokine Protein Expression by BV-2 Cells following  
24 h Co-culture with A. culbertsoni. The RayBio
®
 Mouse Cytokine Antibody Array III 
arrays were used to screen for cytokines and chemokines in supernatants from BV-2 cell 
culture (24 h, MCM) and BV-2 cell plus A. culbertsoni co-culture (24 h, MCM/ACM).  
(A) Membrane arrays comparing cytokine and chemokine proteins of MCM versus 
MCM/ACM. (B) Graphical depiction of select cytokines and chemokines in MCM versus 
MCM/ACM.  The relative amount of each cytokine and chemokine was normalized using 
the average density of the standards (Std.) represented in each membrane.  Cytokines and 
chemokines are labeled: (1) G-CSF, (2) IL-1α, (3) IL-1β, (4) IL-12p40/70, (5) MCP-1, 
(6) MIP-1α, (7) MIP-1γ, (8) MIP-2, (9) MIP-3β, (10) MIP-3α, (11) PF-4, (12) P-Selectin, 
(13) RANTES, (14) TNF-α, (15) sTNF RI, and (16) sTNF RII.  * indicates a ≥ 2.1 fold 
increase as compared to MCM, + indicates a ≥ 2.1 fold decrease as compared to MCM.  
A 
B 
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A. culbertsoni (Figure 12).  Levels of MCP-1, MIP-1α, MIP-1γ, MIP-2, MIP-3β, MIP-
3α, P-Selectin, sTNF RI, and sTNF RII in 24 h supernatants from BV-2 cells maintained 
in the absence of A. culbertsoni were similar to those of BV-2 cells co-cultured with A. 
culbertsoni (Figure 13).  Augmented levels of G-CSF (4.5 fold increase), IL-12p40/70 
(3.7 fold increase), and TNF-α (4.7 fold increase) were observed from co-culture 
supernatants as compared to supernatants from BV-2 cell cultures maintained in the 
absence of A. culbertsoni for 24 h (Figure 13).  An increase in IL-1α levels (1.7 fold 
increase) was also observed in supernatants from co-cultures of BV-2 cells and A. 
culbertsoni (Figure 13). In addition, a decrease in PF-4 (2.2 fold decrease) and normal T-
cell expressed and secreted (RANTES) (2.1 fold decrease) was observed from co-culture 
supernatants as compared to supernatants for BV-2 cell cultures maintained in the 
absence of A. culbertsoni for 24 h (Figure 13).  Notably, there was an overall decrease in 
MIP-3α (5.0 fold decrease) and TNF-α (3.8 fold decrease) levels in 24 h co-culture 
supernatants as compared to 9 h co-culture supernatants (Figures 12 and 13).   
Light microscopy was used to observe the morphology of BV-2 cells, A. 
culbertsoni, and BV-2 cell plus A. culbertsoni co-cultures maintained in CNBA for 9-24 
h (Figure 14).  BV-2 cells maintained in the absence of A. culbertsoni (9-24 h) were 
attached to the plastic substratum and displayed a ramified morphology, consistent with 
these microglial-like cells being in a resting state (Figure 14 A-C).  A. culbertsoni 
maintained in the absence of BV-2 cells (9-24 h) were observed attached to the plastic 
substratum and in their trophozoite form with multiple vacuoles (Figure 14 D-F).  BV-2 
cells co-cultured with A. culbertsoni (9-24 h) were observed in a rounded (i.e., amoeboid)  
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Figure 14: Light Microscopy Images of BV-2 Cells, A. culbertsoni, and BV-2 Cells 
Plus A. culbertsoni Co-cultures. 10
6
 BV-2 cells, 10
6 
A. culbertsoni, and 10
6
 BV-2 cells 
plus 10
6
 A. culbertsoni were cultured for 9 h (A, D, G), 15 h (B, E, H), and 24 h (C, F, I).   
(A-C)  BV-2 cell cultures, (D-F) A. culbertsoni cultures, and (G-I) BV-2 cell plus A. 
culbertsoni co-cultures. Arrows in A-C indicate BV-2 cell processes associated with 
ramified morphology.  Arrows in D-F indicate vacuoles associated with A. culbertsoni 
trophozoites.  Arrows in G-H indicate BV-2 cells.  40x magnification. 
 
  
A 
B 
C I 
H 
G D 
E 
F 
44 
 
form and detached from the plastic substratum, which is consistent with these cells being 
in a reactive or cytotoxic state (Figure 14 G-I). Notably, BV-2 cells maintained 24 h in 
the presence of A. culbertsoni were observed to be over 90% detached from the plastic 
substratum (Figure 14 I).  A. culbertsoni morphology in co-culture with BV-2 cells was 
similar to that for cultures of A. culbertsoni maintained in the absence of BV-2 cells 
(Figure 14 G-I). 
 
Acanthamoeba culbertsoni Elicited Factors Degrade Constitutively-Expressed 
Microglial-Like Cell Cytokines and Chemokines.  
In order to determine further the effect of A. culbertsoni on cytokines and 
chemokines elicited from BV-2 cells, BV-2 cells were cultured in the absence (8 and 18.5 
h) or presence (4-18.5 h) of 0.70 mg/ml of ACM-HI and levels of cytokines and 
chemokines were assessed by cytokine/chemokine protein microarray (Figure 15).  A 
concentration of 0.70 mg/ml ACM-HI represented a 1:2.5 dilution (dilution factor 
calculated based on the average ACM-HI concentration in all experiments represented) of 
the original ACM-HI medium.  Supernatant from BV-2 cells maintained in the absence of 
ACM-HI for 8 h elicited MCP-1, MIP-1α, MIP-1γ, MIP-2, PF-4, P-Selectin, regulated on 
activation, RANTES, sTNF RI, and sTNF RII (Figure 15).  The relative amount of all of 
these immune factors was increased in supernatants from BV-2 cells maintained in the 
absence of ACM-HI for 18.5 h (Figure 15).  In addition, eotaxin-2 also was elicited by 
BV-2 cells in the absence of ACM-HI following culture for 18.5 h (Figure 15).  In 
contrast, supernatant from BV-2 cells maintained in the presence of ACM-HI for 4-8 h  
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Figure 15: Conditioned Medium from A. culbertsoni Degrades Constitutively 
Expressed Cytokines and Chemokines Elicited by BV-2 Cells. The RayBio
®
 Mouse 
Cytokine Antibody Array III arrays were used to screen for cytokines and chemokines in 
supernatants from BV-2 cell cultures maintained in Neurobasal-A medium (control 
medium; BV-2) for 8-18.5 h or in ACM-HI (BV-2 + ACM-HI) (0.70 mg/ml) for 4-18.5 
h.  Chemokines are labeled: (5) MCP-1, (6) MIP-1α, (7) MIP-1γ, (8) MIP-2, (11) PF-4, 
(12) P-Selectin, (13) RANTES, (15) sTNF RI, (16) sTNF RII, and (17) Eotaxin-2. 
Internal standards are labeled “Std”.  
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exhibited overall diminished levels of constitutively expressed cytokines and chemokines 
(Figure 15).  In addition, culturing BV-2 cells in the presence of ACM-HI for 18.5 h 
resulted in the complete depletion of constitutively expressed cytokines and chemokines 
(Figure 15).   
 Morphological studies using light microscopy revealed that BV-2 cells 
maintained for 18.5 h in the absence of ACM-HI displayed a ramified morphology 
(Figure 16).  However, BV-2 cells exposed to ACM-HI for 4-8 h displayed an amoeboid 
morphology consistent with BV-2 cells being in an active state or exhibiting incipient 
cytotoxicity.  Maintenance of BV-2 cells in the presence of ACM-HI for 18.5 h resulted 
in an amoeboid morphology that exhibited membrane blebbing in > 50% of BV-2 cells, 
ruptures in cell membranes, and extrusion of cytosol (Figure 16).   These observations 
are in agreement with factors elicited from A. culbertsoni, present in high concentration, 
being cytotoxic to BV-2 cells. 
In order to further confirm if factors elicited from A. culbertsoni could deplete 
BV-2 cell pro-inflammatory cytokines and chemokines, BV-2 cells were exposed to 100 
ng/ml LPS for 8 h, culture supernatant was collected (LPS/MCM), then incubated in the 
absence or presence of ACM-HI (0.70 mg/ml) for an additional 8 h.   The presence of 
cytokine and chemokine proteins in resulting supernatants was assessed by 
cytokine/chemokine protein microarray (Figure 17). A concentration of 0.70 mg/ml 
ACM-HI represented a 1:2.5 dilution (dilution factor calculated based on the average 
ACM-HI concentration in all experiments represented) of the original ACM-HI medium 
to LPS/MCM.  LPS treatment of BV-2 cells resulted in a robust induction of cytokines  
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Figure 16: Effect of 10
9
 A. culbertsoni-Conditioned Medium (ACM-HI) on BV-2 Cell 
Morphology.  BV-2 cells were cultured in NeurobasalA medium (control medium) or 
treated with ACM-HI (0.70 mg/ml) for 4-18.5 h.  Arrows indicate areas of cytosol 
extrusion at 18.5 h.  40x magnification. 
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Figure 17: Conditioned Medium from A. culbertsoni Degrades Cytokines and 
Chemokines Elicited from Lipopolysaccharide (LPS) Stimulated BV-2 Cells.  BV-2 
cells were stimulated (8 h) with 100 ng/ml LPS and culture supernatant (LPS/MCM) was 
collected. Then, LPS/MCM was incubated with ACM-HI (0.70 mg/ml) (B) or an equal 
volume of complete Neurobasal™-A medium (control) for 8 h (A). Cytokines and 
chemokines are labeled: (1) G-CSF, (4) IL-12p40/70, (5) MCP-1, (6) MIP-1α, (7) MIP-
1γ, (8) MIP-2, (13) RANTES, (14) TNF-α (15) sTNF RI, (16) sTNF RII, and (18) GM-
CSF, (19) IL-6.    
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and chemokines. BV-2 cell stimulation with LPS induced the production of G-CSF, 
granulocyte macrophage-colony stimulating (GM-CSF), interleukin-6 (IL-6), IL-
12p40/70, MCP-1, MIP-1α, MIP-1γ, MIP-2, RANTES, TNF-α, sTNF RI, and sTNF RII 
(Figure 17).  Thus, the profile for LPS induction of cytokines and chemokines from BV-
2 cells differed from that resulting from induction with A. culbertsoni.  In particular, 
robust levels of IL-6 were elicited in the presence of LPS and not in the presence of A. 
culbertsoni.  Incubation of LPS/MCM with ACM-HI (0.70 mg/ml) for 8 h resulted in 
nearly complete depletion of cytokines and chemokines (Figure 17).  
 
Acanthamoeba culbertsoni Serine Proteases Are Associated with the Degradation of 
A. culbertsoni-Stimulated Microglial-Like Cell Cytokines and Chemokines.  
In order to determine whether A. culbertsoni proteases could exert a similar effect 
on cytokines and chemokines elicited from BV-2 cells in the presence of A. culbertsoni, 
BV-2 cells and A. culbertsoni were co-cultured for 24 h (1:1 ratio), the culture 
supernatants (presumably containing amoebae-elicited proteases plus cytokines and 
chemokines produced by BV-2 cells)  were collected and incubated for an additional 72 
h, and the presence of cytokine and chemokine proteins were assessed by protein 
microarray (Figure 18).  Using this approach, a decrease in MIP-1α (8.3 fold decrease), 
PF-4 (2.1 fold decrease), and RANTES (2.1 fold decrease) was observed from co-culture 
supernatants as compared to supernatants for BV-2 cell cultures maintained in the 
absence of A. culbertsoni (Figure 18).  Levels of TNF-α and sTNF RI were also 
decreased (1.8 fold decrease and 1.7 fold decrease, respectively) (Figure 18). 
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Figure 18: Acanthamoeba culbertsoni Proteases Degrade A. culbertsoni Induced 
Microglial Chemokines from BV-2 Cells. BV-2 cells (10
6
) were cultured alone or co-
cultured with A. culbertsoni (10
6
) for 24 h.  The supernatant was harvested and incubated 
an additional 72 h and the relative amount of cytokines and chemokines present was 
measured using RayBio
®
 Mouse Cytokine Antibody Array III assay.  (A) Membrane 
array for culture supernatant from BV-2 cells (MCM). (B) Membrane array for culture 
supernatant from BV-2 cells co-cultured with A. culbertsoni (MCM/ACM). (C) 
Graphical depiction comparing select chemokines. Chemokines are labeled: (5) MCP-1, 
(6) MIP-1α, (7) MIP-1γ, (8) MIP-2, (11) PF-4, (13) RANTES, (14) TNF-α, and (15) 
sTNF RI.  + indicates a ≥ 2.1 fold decrease as compared to MCM.  
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Protease activity associated with culture supernatants from Figure 18 was 
assessed by gelatin zymography.  BV-2 cells maintained in the absence of A. culbertsoni 
did not exhibit protease activity (Figure 19).  In contrast, A. culbertsoni co-cultured with 
BV-2 cells (24 h) exhibited protease activity at zymogram gel positions that corresponded 
to 187, 97, and 58 kDa.  This protease activity remained stable following an additional 72 
h of incubation at 37ºC (Figure 19). 
In order to determine if A. culbertsoni serine proteases were specifically linked to 
A. culbertsoni stimulated BV-2 cell cytokine and chemokine degradation, BV-2 cells 
were co-cultured with A. culbertsoni for 9-24 h, supernatants were collected and 
incubated an additional 12-48 h in the presence or absence of PMSF.  The levels of TNF-
α, MIP-1α, and MIP-2 proteins in resulting supernatants were assessed by ELISA.  
Previous assessment of cytokines and chemokines using protein microarrays indicated 
that TNF-α expression was optimal at 9 h and that MIP-1α and MIP-2 levels were stable 
up to 24 h.  Thus, 9 h and 24 h co-culture times were chosen for assessment of TNF-α 
and for MIP-1α and MIP-2, respectively.  TNF-α, MIP-1α and MIP-2 were chosen due to 
their roles in: i) recruiting microglia/macrophages (MIP-1α), T cells (MIP-1α), and 
neutrophils (MIP-2) and ii) activating microglia/macrophages for amoebicidal activity 
(TNF-α).   TNF-α, MIP-1α and MIP-2 present in co-culture supernatants in the absence 
of PMSF were degraded in a time-related manner (Figures 20-22).  Specifically, TNF-α 
was decreased by approximately 80% in co-culture supernatants maintained for an 
additional 12 h as compared to levels in initial co-culture supernatants (Figure 20).   
 
 
52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Acanthamoeba culbertsoni Protease Activity Persists in Co-culture 
Supernatants Following Incubation for 72 h.  BV-2 cells (10
6
) were cultured alone or 
co-cultured with A. culbertsoni (10
6
) for 24 h.  The supernatant was harvested, incubated 
an additional 72 h, and protease activity of an equal volume of each supernatant was 
assessed using gelatin zymography.  Supernatants from BV-2 cells alone and BV-2 cells 
co-cultured with A. culbertsoni are designated as “M” and “M/A”, respectively. 
Supernatants from 24 h cultures were considered as the starting time and are labeled 0 h.   
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Figure 20: Acanthamoeba culbertsoni Serine Proteases Degrade TNF-α.  Enzyme 
linked immunosorbent assay (ELISA) was used to measure TNF-α produced by BV-2 
cells (10
6
) co-cultured with A. culbertsoni (10
6
) for 9 h.  The culture supernatant was 
collected and incubated an additional 12-48 h with or without the serine protease 
inhibitor PMSF (1.0 mM).  The percent maximum response was calculated by comparing 
the optical density of samples that were incubated for an additional 12-48 h to optical 
density of the starting co-culture supernatant (i.e., 9 h co-culture supernatant).  The 
optical density of the co-culture supernatant at 9 h was equivalent to 1695 pg/ml TNF-α 
and was considered the 100% value. Samples were performed in triplicate and the 
average optical density of each sample was used to calculate percent maximum response.  
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Figure 21: Acanthamoeba culbertsoni Serine Proteases Degrade MIP-1α.  Enzyme 
linked immunosorbent assay (ELISA) was used to measure MIP-1α produced by BV-2 
cells (10
6
) co-cultured with A. culbertsoni (10
6
) for 24 h.  The culture supernatant was 
collected and incubated an additional 12-48 h with or without the serine protease 
inhibitor PMSF (1.0 mM).  The percent maximum response was calculated by comparing 
the optical density of samples that were incubated for an additional 12-48 h to optical 
density of the starting co-culture supernatant (i.e., 24 h co-culture supernatant).  The 
optical density of the co-culture supernatant at 24 h was equivalent to 3983 pg/ml MIP-
1α and was considered the 100% value.  Samples were performed in triplicate and the 
average optical density of each sample was used to calculate percent maximum response.  
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Figure 22: Acanthamoeba culbertsoni Serine Proteases Degrade MIP-2.  Enzyme 
linked immunosorbent assay (ELISA) was used to measure MIP-2 produced by BV-2 
cells (10
6
) co-cultured with A. culbertsoni (10
6
) for 24 h. The culture supernatant was 
collected and incubated an additional 12-48 h with or without the addition of the serine 
protease inhibitor PMSF (1.0 mM).  The percent maximum response was calculated by 
comparing the optical density of samples that were incubated for an additional 12-48 h to 
optical density of the starting co-culture supernatant (i.e., 24 h co-culture supernatant). 
The optical density of the starting co-culture supernatant was equivalent to 5247 pg/ml 
MIP-2 and was considered the 100% value.   Samples were performed in triplicate and 
the average optical density of each sample was used to calculate percent maximum 
response.    
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Furthermore, TNF-α levels in co-culture supernatants were shown to be decreased by 
approximately 97% following an additional 48 h incubation as compared to levels 
observed in initial co-culture supernatants.   An approximate 88% and 99% reduction in 
MIP-1α levels was observed in co-culture supernatants maintained for an additional 12 h 
and 48 h, respectively, as compared to levels in initial co-culture supernatants (Figure 
21).  In addition, MIP-2 levels were diminished by approximately 50% and 96% in co-
culture supernatants maintained for an additional 12 h and 48 h, respectively, as 
compared to levels in initial co-culture supernatants (Figure 22).  Degradation of TNF-α, 
MIP-1α, and MIP-2 in co-culture supernatants was reversed in the presence of PMSF, 
consistent with A. culbertsoni serine proteases as playing a role in their degradation.  
Specifically, in the presence of PMSF an approximate 60% and 70% difference in TNF-α 
and MIP-1α levels, respectively, was observed in co-culture supernatants incubated for an 
additional 12 h as compared to co-culture supernatants maintained an additional 12 h in 
the absence of PMSF (Figures 20 and 21).  The presence of PMSF in co-culture 
supernatant resulted in the full recovery of MIP-2 levels at all time points studied (Figure 
22). Although there was an overall increase in TNF-α and MIP-1α levels in co-culture 
supernatants maintained in the presence of PMSF as compared to co-culture supernatants 
maintained in the absence of PMSF, a time-related decrease of TNF-α and MIP-1α also 
was observed in co-culture supernatants maintained for an additional 12-48 h in the 
presence of PMSF (Figures 20 and 21).   These observations may represent a natural 
breakdown of these factors within the extracellular milieu; or, they may represent the 
degradation of these factors by other A. culbertsoni elicited enzymes.     
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 Discussion 
 
Acanthamoeba are free-living amoebae that are found worldwide and can cause 
opportunistic infections in humans.  Acanthamoeba have been isolated from a variety of 
environmental sources including air, soil, dust, tap water, freshwater, seawater, 
swimming pools, air conditioning units, and contaminated lens cases [Marciano-Cabral 
and Cabral 2003].  Acanthamoeba have two life cycle stages; the trophozoite and the 
cyst.  The trophozoite stage represents the feeding as well as the infective form of 
Acanthamoeba [Rodriquez-Zaragoza et al. 1994; Marciano-Cabral and Cabral 2003; 
Visvesvara et al. 2007].  The cyst stage represents a dormant phase that is formed under 
adverse environmental conditions such as extreme temperature or pH changes [Marciano-
Cabral and Cabral 2003].   
Acanthamoeba secrete a plethora of enzymes including phospholipases and 
proteases.  It has been demonstrated that pathogenic Acanthamoeba secrete more 
phospholipase A and proteases than non-pathogenic Acanthamoeba [Cursons et al. 1978; 
Misra et al. 1983; Hadás et al. 1993b; Khan et al. 2000].  Additionally, it has been 
demonstrated that pathogenic Acanthamoeba produce serine, cysteine, and metallo- 
proteases [He et al. 1990; Hadás et al. 1993a; Mitro et al. 1994; Mitra et al. 1995; Cao et 
al. 1998; Alfieri et al. 2000; Cho et al. 2000; Hong et al. 2000; Khan et al. 2000; Kong et 
al. 2000; Na et al. 2001; Hong et al. 2002; Na et al. 2002; Alsam et al. 2005 ; Kim et al. 
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2006; Sissons et al. 2006].  In our studies a comparison of two-dimensional (iso-dalt) gel 
electrophoresis proteomic profiles of complete Neurobasal™-A medium versus A. 
culbertsoni-conditioned complete Neurobasal™-A medium (i.e., A. culbertsoni-
conditioned medium) suggested that A. culbertsoni secrete factors that are able to degrade 
albumin and putatively other proteins during in vitro culture.  Our findings are consistent 
with studies by Kong et al. [2000] that demonstrated that a serine protease from A. healyi 
degrades albumin.  Using gelatin zymography, we detected A. culbertsoni-secreted serine 
proteases corresponding to positions at 187, 97, 90, and 58 kDa.  However, protease 
activity located at the position corresponding to 90 kDa was not always observed in our 
gelatin zymography assays of A. culbertsoni-conditioned medium. Thus, it is possible 
that protease activity detected at this position could represent a breakdown product.  Our 
gelatin zymography results are consistent with those obtained from previous studies that 
demonstrated that pathogenic T4 genotype Acanthamoeba secrete serine proteases at 
positions corresponding to 188, 97, and 55 kDa [Cao et al. 1998; Serrano-Luna et al. 
2006].  We propose that the A. culbertsoni serine proteases of the approximate molecular 
weights of 187, 97, and 58 kDa identified in our studies likely represent serine proteases 
similar to that of pathogenic Acanthamoeba T4 genotype identified at 188, 97, and 55 
kDa, respectively.  Differences between the relative molecular weights of serine 
proteases identified in our studies and those of others are likely due to variations in the 
construction of zymography gels. Thus, our results suggest that the T10 genotype A. 
culbertsoni used in our studies may secrete similar serine proteases as pathogenic T4 
genotype Acanthamoeba; suggesting that certain proteases may convey pathogenicity.   
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Using the cysteine protease inhibitor E-64 we did not observe cysteine protease activity 
in A. culbertsoni-conditioned medium.  Studies by Alferi et al. [2000] indicate that 
Acanthamoeba cysteine proteases are most active at pH 4.0-5.0. Our gelatin zymogram 
studies were performed at pH 5.0 and 7.5.  Furthermore, Serrano-Luna et al. [2006] were 
not able to detect cysteine protease activity in Acanthamoeba conditioned medium using 
E-64 at pH 3.0 - 9.0; but, they were successful at detecting cysteine protease activity 
using the cysteine protease inhibitor N-ethylmaleimide (NEM) [Serrano-Luna et al. 
2006].  Thus, their results suggest that E-64 may not be the optimal inhibitor to use for 
the detection of cysteine protease activity in Acanthamoeba-conditioned medium.  Using 
gelatin zymography, we also demonstrated that A. culbertsoni propagation medium does 
not influence the proteolytic profile of A. culbertsoni; however, levels of protease activity 
secreted from A. culbertsoni were affected.  Our results suggest that the higher iron 
content in oxoid medium, which contains neutralized liver digest, as compared to that in 
PYG medium influences the level of protease activity elicited from A. culbertsoni.  Our 
results are consistent with those of Melo-Braga et al. [2003] that demonstrated that iron-
depletion reduces cysteine protease activity elicited from the bovine pathogen 
Tritrichomonas foetus. Collectively, our results indicate that A. culbertsoni secrete 
predominantly serine proteases and highlight the importance of the selection of medium 
used for the growth of Acanthamoeba in various studies since these may affect levels of 
secreted proteases.   Acanthamoeba serine proteases are thought to serve a functional role 
in encystment and excystment of amoeba while they inhabit the environment [Dudley et 
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al. 2008; Moon et al. 2008]. However, it is also thought that serine proteases may play a 
role in Acanthamoeba host invasion and immune evasion.  
Only a select group of Acanthamoeba species, including A. culbertsoni, have been 
linked to disease in humans.  Acanthamoeba are known to cause three types of infections 
in humans; AK, cutaneous acanthamoebiasis, and GAE [Marciano-Cabral and Cabral 
2003; Khan 2006; Visvesvara et al. 2007].  AK is a potentially blinding eye infection that 
is most frequently associated with contact lens wearers and it the most common disease 
caused by Acanthamoeba [Clarke and Niederkorn 2006a].  Cutaneous acanthamoebiasis 
is an Acanthamoeba skin infection that can result in hematogenous spread of 
Acanthamoeba throughout the host.  Cutaneous acanthamoebiasis is commonly 
associated with immune compromised individuals.  Acanthamoeba can also cause a 
chronic and slow progressing CNS disease called GAE. 
  GAE is most prevalent in immune compromised individuals [Marciano-Cabral 
and Cabral 2003].  It is believed that in humans GAE is most often caused by the entry of 
trophozoites into the CNS via hematogenous spread originating from the lungs or 
cutaneous infection [Marciano-Cabral and Cabral 2003; Khan 2008].  However, 
Acanthamoeba trophozoites may also gain access to the CNS via the olfactory 
neuroepithelium.   Studies by Alsam et al. [2005], using a human brain endothelial cell 
model, implicated Acanthamoeba serine proteases in the induction of blood brain barrier 
permeability; thus, demonstrating a potential role of Acanthamoeba serine proteases in 
CNS invasion leading to GAE.  GAE is characterized by the formation of granulomas 
within the CNS; however, granulomas are rarely observed in immune compromised 
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individuals [Martinez 1982].  Granulomas are usually composed of amoebae, microglia, 
macrophages, T cells, B cells, and neutrophils. 
  Microglia, resident brain macrophages, and invading peripheral macrophages 
have been indicated as the primary immune cells that elicit a direct response to CNS 
invading Acanthamoeba [Marciano-Cabral and Cabral 2003].   It has been reported that 
primary rat microglia release pro-inflammatory mediators, such as IL-1α, IL-1β, and 
TNF-α in response to Acanthamoeba [Marciano-Cabral et al. 2004].   Reports also 
indicate that such cytokines are not cytolytic to Acanthamoeba and, rather, may serve to 
activate microglial/macrophage cells for contact-dependent mediated killing of 
Acanthamoeba [Marciano-Cabral et al. 1998].  Indeed, activated microglia and 
macrophages have been demonstrated to be cytolytic (i.e., amoebicidal) to Acanthamoeba 
[Benedetto et al. 2002; Benedetto et al. 2003].  We demonstrated that BV-2 microglial-
like cells produce mRNAs for MCP-1, MIP-1α, MIP-1β, and MIP-2 in response to A. 
culbertsoni.  These observations suggest that exposure of the microglial-like cells to 
Acanthamoeba resulted in de novo gene induction.  The results were extended at the 
protein level wherein MCP-1, MIP-1α, and MIP-1γ were constitutively produced by BV-
2 cells at relatively high levels at early time periods (i.e., 9 h).  Furthermore, we 
demonstrated that A. culbertsoni augmented the protein level of G-CSF, IL-1α, IL-
12p40/70, TNF-α, and MIP-3α secreted by BV-2 cells.   It is important to note that in our 
studies we did not observe an A. culbertsoni-dependent induction of BV-2 cell-elicited 
IL-1β expression as demonstrated in previous studies [Shin et al. 2001; Marciano-Cabral 
et al. 2004].   Thus, differences between our results and those of others are likely due to 
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the differences in microglial cell type and/or culture conditions used.  G-CSF stimulates 
the growth and activation of neutrophils [Fitzgerald et al. 2001].  IL-1α, IL-1β, and TNF-
α are microglial, macrophage, and T cell activating cytokines.  Furthermore, TNF-α plays 
an instrumental role in the activation of microglial and macrophage anti-microbial 
activity via the activation of phagocytosis.  IL-12 serves as an important signal for the 
induction of the Th1 cell phenotype and also serves as a stimulatory signal for Th1 
cytokine secretion; and microglia are thought to represent the main source of IL-12 
within the CNS [Stalder et al. 1997; Aloisi 2001].   MIP-3α stimulates the recruitment of 
activated and memory T cells, dendritic cells, and B cells [Dieu et al. 1998; Tanaka et al. 
1999].  Overall, our results suggest that microglia elicit a variety of cytokines and 
chemokines in response to A. culbertsoni which are capable of autocrine and paracrine 
immune cell activation facilitating the formation of granulomas via the recruitment of 
immune cells, including microglia, macrophages, T cells, B cells, and neutrophils, to 
focal sites of Acanthamoeba within the CNS.  It is important to note that we also 
observed a decrease in sTNF RI and s TNF RII levels in supernatants from BV-2 cells 
stimulated with A. culbertsoni for 9 h as compared to supernatants from un-stimulated 
BV-2 cells.  sTNF RI and sTNF RII represent soluble forms of TNF RI and TNF RII, 
respectively, and their role in CNS immunity has not been fully elucidated; however, 
studies have indicated a link between increased levels sTNF RI in cerebrospinal fluid to 
the clinical onset of multiple sclerosis [Tsukada et al. 1993].  In contrast to the induction 
of pro-inflammatory factors observed at 9 h co-culture, we observed a decrease in levels 
of MCP-1, MIP-1α, MIP-1γ and PF-4 at 9 h. MCP-1 and MIP-1α stimulate the 
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chemotaxis of microglia, macrophages, dendritic cells, and T helper 1 (Th1) cells 
[Peterson et al. 1997; Dieu et al. 1998; Aloisi 2001].  MIP-1γ serves as a chemotactic 
signal for dendritic and memory T cells.  PF-4 recently has been reported to induce the 
migration of microglia via the CXCR3 chemokine receptor [de Jong et al. 2008].  In 
addition, we detected a decrease in PF-4 and RANTES levels in supernatants from BV-2 
cells stimulated with A. culbertsoni for 24 h as compared to supernatants from un-
stimulated BV-2 cells.  RANTES induces the migration of microglia, macrophages, T 
cells, and dendritic cells [Aloisi 2001].  We also observed an overall decrease in the 
levels of TNF-α and MIP-3α protein at 24 h.  The decreases in the aforementioned 
cytokines and chemokines could represent changes in the transcriptional or translational 
regulation of these BV-2 cell-elicited factors in the presence of A. culbertsoni or, 
alternatively, could reflect the degradation of these factors within the extracellular milieu.    
Our studies implicate proteases that are secreted by Acanthamoeba as playing a 
major role in the decrease in levels of chemokines and cytokines in the extracellular 
milieu.  In this context, previous studies have demonstrated that of Acanthamoeba serine 
proteases are able to degrade immune modulating factors such as sIgA, IgG, IgM, IL-1α, 
and IL-1β, implicating these enzymes as playing a role in host immune evasion [Kong et 
al. 2000; Na et al. 2001; Na et al. 2002].  However, in these studies recombinant 
exogenous substrates were used.  Our studies are novel in that they demonstrated that 
proteases elicited by Acanthamoeba degrade cytokines and chemokines natively secreted 
by microglial-like cells.  That is, we observed that constitutively-expressed as well as 
LPS-stimulated cytokines and chemokines from BV-2 cells were degraded in the 
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presence of conditioned medium from A. culbertsoni cultures. Constitutively expressed 
BV-2 cell cytokines and chemokines which were degraded in the presence of A. 
culbertsoni- elicited factors included eotaxin-2, MCP-1, MIP-1α, MIP-1γ, MIP-2, PF-4, 
P-Selectin, RANTES, sTNF RI and sTNF RII. In addition, LPS-stimulated cytokines and 
chemokines were degraded.  LPS-stimulated BV-2 cell cytokines and chemokines which 
were degraded in the presence of A. culbertsoni-elicited factors included G-CSF, GM-
CSF, IL-6, IL-12p40/p70, MCP-1, MIP-1α, MIP-1γ, MIP-2, RANTES, TNF-α, sTNF RI, 
and sTNF RII.  It is important to note that the pattern of cytokines and chemokines 
elicited by LPS-stimulated BV-2 cells was different than that of A. culbertsoni- 
stimulated BV-2 cells.  In particular, LPS caused BV-2 cells to elicit a high level of IL-6 
which was not detected when BV-2 cells were stimulated with A. culbertsoni.  Moreover, 
MIP-3α and MIP-3β were elicited by A. culbertsoni-stimulated BV-2 cells and not by 
LPS-stimulated BV-2 cells.  Furthermore, our studies suggest that A. culbertsoni serine 
proteases are specifically linked to the degradation of microglial cytokines and 
chemokines (e.g. TNF-α, MIP-1α, and MIP-2).  Our results parallel findings of others 
that demonstrate that the serine proteases cathepsin G, elastase, and proteinase 3 degrade 
human MIP-1α; and that a Group A streptococcal serine protease degrades MIP-2 [Ryu et 
al. 2005; Hidalgo-Grass et al. 2006].  Furthermore, studies by Ferrante and Bates [1988] 
indicate that A. culbertsoni elicit an elastase; thus, it can be postulated that this serine 
protease may also be linked to the degradation of microglial-secreted cytokines and 
chemokines.  Collectively, our results suggest that A. culbertsoni-elicited factors degrade 
endogenously produced BV-2 cell-elicited cytokines and chemokines, indicating a mode 
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by which A. culbertsoni applies a contact-independent mechanism to dampen microglial 
facilitated CNS immune cell responsiveness which, in turn, may lead to the downstream 
diminution of granuloma formation and microglial/macrophage anti-microbial activity.   
We also detected a time-related augmentation in the level of serine protease 
activity from A. culbertsoni in the presence of BV-2 cells.  The augmentation in A. 
culbertsoni serine protease activity in conditioned medium may be linked to A. 
culbertsoni binding to microglial-like cells via trophozoite expressed mannose-binding 
protein (MBP), and is consistent with reports that binding of Acanthamoeba to mannose 
on human brain microvascular endothelial cells via Acanthamoeba-expressed MBP 
increases the amount of secreted protease [Alsam et al. 2003; Alsam et al. 2005].  One 
mode by which A. culbertsoni serine proteases affect microglial responsiveness may be 
through activation of microglial-expressed receptors called protease-activated receptors 
(PARs), the activation of which results in the release of microglial cytokines and 
chemokines.  PARs are a group of G-protein coupled receptors that are activated by 
serine and cysteine proteases.  To date, four PARs have been described; PAR1, PAR2, 
PAR3, and PAR4. PARs are expressed by a variety of cells including platelets, 
endothelial cells, epithelial cells, monocytes, T cells, natural killer (NK) cells, astrocytes, 
neurons, and microglia [Balcaitis et al. 2003; Steinhoff  et al. 2005].  We have confirmed 
published reports that BV-2 cells express mRNA for PAR1, PAR3, and PAR4 (data not 
shown) [Balcaitis et al. 2003].  PARs are activated when proteases recognize and cleave a 
specific amino acid sequence located at the N-terminus of the receptor; the resulting N-
terminus acts as a tethered ligand by binding back on the receptor’s extracellular loop 
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region.  PAR1 can be activated by thrombin, Factor Xa, plasmin, and activated protein C 
[Ossovskaya and Bunnett 2004; Steinhoff et al. 2005].  PAR2 can be activated by trypsin, 
tryptase, Factor VIIa, Factor Xa, and exogenous proteases such as gingipain-R of 
Porphyromonas gingivalis [Ossovskaya and Bunnett 2004; Steinhoff et al. 2005].   PAR3 
is believed to act as a cofactor for PAR4; and, PAR3 and PAR4 can be activated by 
thrombin and cathepsin G [Nakanishi-Matsui, 2000; Steinhoff et al. 2005].  Activation of 
PARs has been linked to inflammation [Steinhoff et al. 2005].  Specifically, it has been 
suggested that PAR1 activation leads to the production of IL-1, IL-6, and MCP-1 by 
monocytes [Colotta et al. 1994; Naldini et al. 2000; Naldini et al. 2002; Steinhoff et al. 
2005; Li et al. 2006].  PAR1 activation has also been linked to IL-8 production in 
macrophages [Zheng et al. 2007].  Activation of monocyte expressed PAR2 has been 
demonstrated to induce IL-1β, IL-6, and IL-8 production [Johansson et al. 2005].    PAR4 
has been linked to IL-6 production by monocytes [Li et al, 2006].  Thus, we propose that 
it is possible that A. culbertsoni serine proteases act through BV-2 microglial-like cell- 
expressed PARs leading to the secretion of cytokines and chemokines observed in our 
studies.  However, further studies using specific PAR agonists and antagonists/blockers 
would be required in order to establish a functional linkage between in A. culbertsoni-
elicited serine protease and microglial-cell cytokine/chemokine production.  
 Proteases acting through PAR receptors have been linked to cell apoptosis 
[Steinhoff et al. 2005].  For example, PAR1 thrombin activation has been demonstrated 
to induce neuronal cell apoptosis [Smirnova et al. 1998]. These observations are 
consistent with our results from our light microscopy studies which demonstrated that 
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conditioned medium from A. culbertsoni is toxic to BV-2 cells suggestive of apoptosis.  
Additionally, these findings are in agreement with those that demonstrated that 
Acanthamoeba elicited factors induce morphological changes and lysis of epithelial cells 
[Mattana et al. 1997].    
In summary, while it is likely that Acanthamoeba uses a multiplicity of contact-
dependent and contact-independent mechanisms to elicit pathology within the CNS 
during GAE, our results suggest that Acanthamoeba have developed strategies via the 
elicitation of serine proteases to aid immune evasion in that compartment.  Specifically, 
we postulate that serine proteases released by Acanthamoeba initially act on microglia to 
induce the production of a plethora of cytokines and chemokines, possibly mediated 
through the activation of PAR receptors on microglia.   These cytokines and chemokines 
elicited by microglia in response to Acanthamoeba serve to activate and recruit additional 
microglia, macrophages, T cells, and neutrophils to focal sites of infection leading to the 
formation of granulomas.  Within these granulomas it is postulated that microglia and 
macrophages are activated by T cell-elicited IFN-γ in combination with T 
cell/microglial/macrophage-elicited TNF-α, leading to microglial/macrophage-dependent 
amoebicidal activity [Benedetto et al. 2002; Benedetto et al. 2003].  However, under 
conditions of high Acanthamoeba burden when relatively high concentrations of 
Acanthamoeba may be present, we suggest that the attendant higher concentration of 
Acanthamoeba serine proteases leads to the degradation of microglial cytokines and 
chemokines. This diminution, in turn, may lead to a decrease in microglial/macrophage 
activation resulting in the decrease of granuloma formation and microglial/macrophage 
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anti-microbial activity.  The resultant outcome is dissemination of Acanthamoeba within 
the CNS and progressive neuropathology.   Additionally, our results suggest that 
Acanthamoeba proteases induce microglial cell apoptosis, thus, representing a means by 
which these opportunistic pathogens may process microglia as a source of food.  In 
conclusion, our results suggest that Acanthamoeba serine proteases provide a multi-tailed 
approach for Acanthamoeba to effectively evade host CNS immunity.   Furthermore, it 
can be postulated that appropriately designed therapeutics which block the potential 
activation of microglial expressed PARs by Acanthamoeba elicited serine proteases used 
in combination with current therapeutic approaches could prove to be an effective means 
of benefiting the clinical outcome of patients with GAE.   
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